Amokit - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 457,064 | 157,034 | 445,016 | 303,283 | 324,952 | 157,868 | 239,364 | 191,612 |
| Profit before tax | 72,276 | -3,316 | 111,607 | 72,072 | -266,922 | - | - | 38,368 |
| Net profit | 61,418 | -3,316 | 94,858 | 61,256 | -267,922 | -9,015 | 44,842 | 36,093 |
| Equity | 133,413 | 121,629 | 216,487 | 278,241 | 10,319 | 1,304 | 46,146 | 82,239 |
| Liabilities | 139,957 | 167,076 | 125,311 | 87,589 | 194,942 | 71,957 | 59,365 | 59,909 |
| Non-current assets | 3,063 | 61,332 | 46,904 | 32,785 | 959 | 698 | 438 | 373 |
| Current assets | 270,307 | 227,373 | 294,894 | 333,045 | 204,302 | 72,563 | 105,073 | 141,775 |
| Total assets | 273,370 | 288,705 | 341,798 | 365,830 | 205,261 | 73,261 | 105,511 | 142,148 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 261 | - | 5,679 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -58.3% | -65.6% | +183.4% | -31.8% | +7.1% | -51.4% | +51.6% | -19.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 22.5% | -1.1% | 27.8% | 16.7% | -130.5% | -12.3% | 42.5% | 25.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 46.0% | -2.7% | 43.8% | 22.0% | -2596.4% | -691.3% | 97.2% | 43.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 13.4% | -2.1% | 21.3% | 20.2% | -82.4% | -5.7% | 18.7% | 18.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 15.8% | -2.1% | 25.1% | 23.8% | -82.1% | - | - | 20.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.0 | 1.4 | 0.6 | 0.3 | 18.9 | 55.2 | 1.3 | 0.7 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 189,127 | 72,476 | 222,508 | 151,642 | 162,476 | 78,934 | 119,682 | 95,806 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Amokit - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-02-17 | 2023-02-20 | 0.62 |
| 2023-02-06 | 2023-02-06 | 0.62 |
| 2023-01-20 | 2023-02-03 | 0.62 |
| 2022-11-17 | 2022-11-18 | 411.67 |
Amokit - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Amokit, UAB (code 302571029) is a private limited liability company engaged in the wholesale of pharmaceutical and medical goods. In the latest financial year, 2025, the company generated revenue of €191.6K, which was 19.9% lower than in 2024, but still above the 2023 level of €157.9K. Net profit in 2025 reached €36.1K, compared with a net loss of €9.0K in 2023 and a stronger profit of €44.8K in 2024. The 2025 profit margin was 18.8%, showing that the business remained profitable despite lower sales. Over the three-year period, the company moved from a loss in 2023 to solid profitability in 2024 and 2025. At the end of 2025, total assets stood at €142.1K, equity at €82.2K and liabilities at €59.9K. The equity ratio was 57.9%, debt-to-equity was 0.73, ROE reached 43.9% and ROA 25.4%. Asset turnover was 1.35x. Revenue per employee was €95.8K and profit per employee €18.0K, indicating efficient operations.